U.S. Office REITs Stock News

Earlier this week, Wells Fargo and other analysts raised their outlooks on Antero Midstream, while the company moved its funding mix toward newly issued Notes and away from legacy debt facilities. This combination of stronger analyst sentiment and a simplified capital structure has sharpened investor focus on how Antero Midstream intends to finance future growth and distributions. We’ll now examine how Antero Midstream’s shift toward Notes-based funding could influence its investment...

Signet Jewelers (SIG) has quietly become one of retail’s more interesting value stories, with the stock up about 12% this year but still giving back some gains over the past month and past 3 months. See our latest analysis for Signet Jewelers. At around $87.01 per share, Signet’s recent pullback, including a weaker 1 month share price return after a solid year to date share price gain, looks more like cooling momentum than a broken story, especially given its strong 5 year total shareholder...

Amcor plc has confirmed it will implement a previously approved 1-for-5 reverse stock split, effective after the close of trading on January 14, 2026, consolidating its approximately 2.30 billion outstanding ordinary shares into about 0.46 billion and proportionately adjusting authorized share capital, par value, CHESS Depositary Interests, and equity-based awards. The move simplifies Amcor's capital structure and lifts the per-share reference price, while cashing out fractional holdings and...

Invitation Homes (INVH) just gave income investors something to chew on, lifting its quarterly dividend by 3.4% to 0.30 dollars a share, with the new payout tied to a late December record date. See our latest analysis for Invitation Homes. The higher dividend lands at a time when Invitation Homes shares trade around 27.32 dollars, with a year to date share price return in negative territory but a modestly positive three year total shareholder return suggesting longer term momentum is still...

Relay Therapeutics (RLAY) just put fresh clinical data for its PI3K alpha inhibitor zovegalisib in front of oncologists at the San Antonio Breast Cancer Symposium, and the subset analysis immediately sharpened the stock’s risk reward profile. See our latest analysis for Relay Therapeutics. The zovegalisib update lands after a sharp rebound in sentiment, with a roughly 97 percent 90 day share price return and a 104 percent one year total shareholder return, even though the five year total...

Immunome (IMNM) just delivered a big one two for investors, first unveiling strong Phase 3 RINGSIDE data for varegacestat in desmoid tumors, then swiftly raising about $400 million through a follow on stock offering. See our latest analysis for Immunome. Those blockbuster Phase 3 results and the follow on raise have not gone unnoticed, with the share price climbing to $22.33 and delivering a 90 day share price return of about 120 percent, while the three year total shareholder return is...

T-Mobile US recently reinforced its market position by being named America’s Best Network, launching T-Satellite direct-to-cell service with Starlink, rolling out 5-year price-guaranteed plans, and expanding into fiber broadband while intensifying competitive pressure on rivals such as Verizon. Beneath the consumer-friendly promotions and disaster-resilience initiatives, T-Mobile’s ongoing 5G and fiber build-out highlights a push to deepen customer relationships across both mobile and home...

Simpson Manufacturing (SSD) just lined up $900 million in new five year credit facilities, refinancing older debt while opening fresh capacity for acquisitions, investments, and day to day liquidity that could reshape its growth path. See our latest analysis for Simpson Manufacturing. The fresh $900 million credit package lands at a time when Simpson Manufacturing’s share price has been broadly steady, with a modest year to date share price gain and a standout three year total shareholder...

KBR (KBR) just slid about 5% after the Lake Charles LNG export project was suspended, a move that has sharpened investor focus on how much of the company’s future depends on big engineering work. See our latest analysis for KBR. The Lake Charles setback comes after a mixed stretch for the stock, with a 1 year to date share price return of around minus 30 percent and a 1 year total shareholder return of roughly minus 29 percent. At the same time, new defense and energy transition wins hint...

Caliber’s decision to tap StoneX Group (SNEX) as an institutional trading and custody partner for its Digital Asset Treasury strategy puts StoneX squarely in the path of growing institutional demand around blockchain linked reserves. See our latest analysis for StoneX Group. That backdrop helps explain why investors have been steadily re-rating StoneX, with the share price now at $98.07 and a strong year to date share price return of 46.8 percent, alongside a robust 5 year total shareholder...

Americold Realty Trust (COLD) has quietly staged a sharp rebound this month, even as its longer term returns remain deeply negative. That mix of short term strength and multi year pain is exactly what makes the stock interesting now. See our latest analysis for Americold Realty Trust. The recent 20.1% 1 month share price return to $12.57 has sparked some optimism, but it comes after a heavy 41.1% year to date share price decline and multi year total shareholder losses. This suggests sentiment...

Viatris (VTRS) just gave investors a fresh catalyst by unveiling four regulatory milestones, including FDA approval for its generic Sandostatin LAR Depot and progress on a contraceptive patch and an eye disease candidate. See our latest analysis for Viatris. Those regulatory wins seem to be shifting sentiment, with Viatris’ roughly 29 percent 3 month share price return at a 12.24 share price and solid 3 year total shareholder return suggesting momentum is rebuilding after a softer year to...

Grand Canyon Education (LOPE) just posted revenue growth of about 10% in line with expectations, but its softer full year earnings guidance and lag versus peers quickly turned the spotlight to profitability. See our latest analysis for Grand Canyon Education. That cautious EPS outlook helps explain why, even with a solid 30 day share price return of 8.35 percent, Grand Canyon Education is still working off a 21.51 percent 90 day share price pullback. This leaves long term total shareholder...

Wondering if Constellation Energy at around $363 a share is still a smart buy after its massive run, or if you are turning up late to the party? This article examines whether the current price still stacks up against the company fundamentals. The stock has climbed about 6.7% over the last week and 2.8% over the past month, with an eye catching 50.0% year to date and 59.3% over the last year, on top of a 330.7% gain over three years. Recently, investors have been focused on Constellation...

Freshpet (FRPT) has quietly staged a strong rebound this month, rising about 19% and roughly 30% over the past 3 months, even as its one year return remains sharply negative. See our latest analysis for Freshpet. That recent rebound has helped the stock claw back some ground, but with a 1 year total shareholder return still deeply negative versus a positive 3 year total shareholder return, the latest 30 day and 90 day share price momentum looks more like a tentative reset than a full...

Steady gains and what they might mean for investors Textron (TXT) has quietly put together a solid run, with the stock up about 10% over the past month and nearly 20% year to date, catching the attention of patient investors. See our latest analysis for Textron. The latest 10.3% 1 month share price return, combined with a 19.9% year to date share price gain and strong multi year total shareholder returns, suggests momentum is building as investors warm to Textron’s steady execution and modest...

Rezolute (RZLT) just released topline data from its pivotal Phase 3 sunRIZE trial in congenital hyperinsulinism, and the drug missed both primary and key secondary endpoints, forcing investors to quickly reassess the story. See our latest analysis for Rezolute. The setback helps explain why Rezolute’s 30 day share price return sits at around negative 72 percent even after a sharp short term rebound. The share price closed at 2.74 dollars, and while the three year total shareholder return is...

Wondering whether Chemours at around $12 is a bargain or a value trap? You are not alone, and this breakdown is designed to help you decide with a clear, valuation-first lens. Despite a tough longer-term picture, with the stock still down 29.0% over the past year and 55.1% over three years, it has shown some short-term life, rising 3.4% in the last week and 4.3% over the past month, even though it remains down 28.2% year to date. Recent moves have been shaped by ongoing headlines around...

NGL Energy Partners LP recently declared quarterly distributions for its 11.460% Class B and 11.369% Class C Floating Rate Cumulative Redeemable Perpetual Preferred Units, along with a US$14,618,325.21 cash distribution for its Class D Preferred Units, all payable on January 15, 2026 to holders of record on January 1, 2026. This comes as NGL Energy Partners has been benefiting from a very large upward revision in full-year earnings estimates and a higher Zacks Rank, signaling a shift in...

In December 2025, the state of Maryland selected ICF International as one of eight prime awardees on a US$300 million, nine-year Agile Digital Experience Product Transformation contract to modernize digital services across state and local agencies. This long-duration, statewide digital transformation vehicle underscores ICF’s role in overhauling legacy government systems using agile, human-centered design and enterprise architecture, potentially reinforcing its broader government technology...

CarMax, Inc. has already reported third-quarter 2025 results showing sales of US$150.63 million and net income of US$62.22 million, alongside ongoing share repurchases and multiple securities class action lawsuits alleging misleading disclosures around demand and its auto finance portfolio. Beyond weaker earnings, the combination of leadership transition, aggressive cost-cutting plans, and legal scrutiny raises fresh questions about the durability and quality of CarMax’s growth...

Permian Resources (PR) just kicked off a restructuring that shifts management and long-term holders from Class C to Class A shares under a new holding company, tightening alignment with everyday shareholders. See our latest analysis for Permian Resources. That backdrop helps explain why the latest holding company cleanup comes as the share price sits around $13.88, with near term share price momentum soft but long term total shareholder returns still very strong, suggesting sentiment is...

Charles Schwab (SCHW) just cleared the psychologically important 100 dollar mark, and it did not happen in a vacuum. The move lines up with a broader overhaul of its trading platforms and product lineup. See our latest analysis for Charles Schwab. That breakout above 100 dollars is part of a clear upswing, with a roughly 12 percent 1 month share price return and a 5 year total shareholder return above 100 percent. This suggests momentum is firmly rebuilding around Schwab’s repositioning...

In recent weeks, Intuitive Surgical received expanded FDA clearance for its da Vinci Single Port system to perform three common general surgery procedures, inguinal hernia repair, cholecystectomy, and appendectomy, broadening the platform’s use beyond its earlier urology, colorectal, thoracic, and transoral indications. This wider procedural toolkit, combined with ongoing enhancements in digital and AI capabilities, meaningfully deepens the company’s role in everyday minimally invasive...